Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Acetaminophen for Acute Sickle Cell Crisis Pain in Pediatric ED
NCT03541980Phase 4Completed
- Sponsor
- Newark Beth Israel Medical Center
- Start
- Feb 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetaminophen in sickle cell anemia (SCA) (2 arms), sponsored by Newark Beth Israel Medical Center. Primary endpoint: Cumulative Opioid Dosing at 120 minutes. Started Feb 2018; status: completed.
02
Drugs
acetaminophen
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT03541980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03541980.